Executive summary of the consensus document for the management of severe Cushing's syndrome: Consensus document of the Neuroendocrinology Focus Group of the Spanish Society of Endocrinology and Nutrition (SEEN)


Por: Araujo-Castro, M, García-Centeno, R, Aller, J, Marazuela, M, Soto, A, Gálvez, MA, Cámara, R, Valassi, E, Bernabeu, I, Villar-Taibo, R and Hanzu, FA

Publicada: 1 dic 2025 Ahead of Print: 1 dic 2025
Resumen:
Severe Cushing's syndrome (SCS) is usually defined as a CS with urinary free cortisol (UFC) levels above five times the upper limit of normal or associated with severe complications of hypercortisolism. Combination therapy with ketoconazole and metyrapone is a useful option for these patients. Osilodrostat is the most potent and effective oral drug in monotherapy for the treatment of SCS. For cases with very severe hypercortisolism and/or oral intolerance, etomidate is the most effective and rapid drug for reducing cortisol levels. Bilateral adrenalectomy may be indicated in cases of life-threatening severe hypercortisolism, but UFC should be reduced before surgery to reduce the perioperative morbimortality. Prompt treatment of comorbidities and thrombo-and infection prophylaxis are recommended. In conclusion, a rapid control of hypercortisolism is vital in SCS, and for this purpose combination therapy or potent drugs with a rapid onset of action such as etomidate or osilodrostat are indicated. (c) 2025 SEEN and SED. Published by Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Filiaciones:
Araujo-Castro, M:
 Hosp Univ Ramon y Cajal, Endocrinol & Nutr Dept, Madrid, Spain

 Inst Invest Biomed Ramon y Cajal IRYCIS, Madrid, Spain

García-Centeno, R:
 Hosp Univ Gregorio Maranon, Endocrinol & Nutr Dept, Madrid, Spain

Aller, J:
 Hosp Univ Puerta Hierro Majadahonda, Endocrinol & Nutr Dept, Madrid, Spain

Marazuela, M:
 Hosp Univ La Princesa, Endocrinol & Nutr Dept, Madrid, Spain

Soto, A:
 Hosp Univ Virgen del Rocio, Endocrinol & Nutr Dept, Seville, Spain

Gálvez, MA:
 Hosp Univ Reina Sofia, Endocrinol & Nutr Dept, Cordoba, Spain

Cámara, R:
 Hosp Univ & Politecn La Fe, Endocrinol & Nutr Dept, Valencia, Spain

:
 Hosp Univ Inst Invest Germans Trias i Pujol, Endocrinol & Nutr Dept, Badalona, Barcelona, Spain

 Univ Int Catalunya, Bioengn Inst Technol, Grp CIBERER 747 Enfermedades hipofisis, Barcelona, Spain

Villar-Taibo, R:
 Hosp Univ Santiago Compostela, Endocrinol & Nutr Dept, Galicia, Spain

Hanzu, FA:
 Hosp Clin Barcelona, Endocrinol & Nutr Dept, IDIBAPS, Barcelona, Spain
ISSN: 25300180





Endocrinologia Diabetes y Nutricion
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, España
Tipo de documento: Article
Volumen: 72 Número: 10
Páginas: 501654-501654
WOS Id: 001645406400001
ID de PubMed: 41419261

MÉTRICAS